T Wengenmayer1, J Reinöhl1, J Steinfurt1, A Mittag2, C Bode1, J Biermann3. 1. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. 2. IMTR, Institute of Medical Technology and Research, Rottmersleben, Germany. 3. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. biermannj@web.de.
Abstract
BACKGROUND: Cardiac resynchronisation therapy (CRT) is an established treatment option for chronic heart failure patients with left bundle branch block. Although a concomitant functional mitral regurgitation is often reduced by CRT, many patients need additional mitral valve repair. Placing a CARILLON® Mitral Contour System (CMCS) over a transvenous CRT lead is currently not recommended, since both of them are implanted in the coronary sinus (CS). The aim of this study was to investigate the feasibility of sequential implantation of a transvenous LV lead followed by CMCS implantation, and to assess LV lead performance and possibility of extraction. METHODS AND RESULTS: Standard transvenous LV leads were implanted in the CS of five female sheep. After establishing regular anatomical position with stable electrical parameters of the LV lead, a CMCS was additionally implanted in the CS. After an observation period of 100 days, lead performance and positions of lead and CMCS were studied. Sequential implantation of the two components was feasible in sheep. After 100 days, all leads showed regular measurements of impedance, threshold, and sensing. There was no migration of either the LV lead or the CMCS. In all cases, the LV lead could be completely extracted without migration of the CMCS. There were no acute or long-term complications. CONCLUSIONS: In an animal model of healthy adult sheep, implantation of CMCS with a transvenous LV lead already in place was feasible and without major problems with either the CMCS or the LV lead. Electrical performance of the LV leads was excellent. All LV leads could be extracted without migration of the CMCS.
BACKGROUND: Cardiac resynchronisation therapy (CRT) is an established treatment option for chronic heart failurepatients with left bundle branch block. Although a concomitant functional mitral regurgitation is often reduced by CRT, many patients need additional mitral valve repair. Placing a CARILLON® Mitral Contour System (CMCS) over a transvenous CRT lead is currently not recommended, since both of them are implanted in the coronary sinus (CS). The aim of this study was to investigate the feasibility of sequential implantation of a transvenous LV lead followed by CMCS implantation, and to assess LV lead performance and possibility of extraction. METHODS AND RESULTS: Standard transvenous LV leads were implanted in the CS of five female sheep. After establishing regular anatomical position with stable electrical parameters of the LV lead, a CMCS was additionally implanted in the CS. After an observation period of 100 days, lead performance and positions of lead and CMCS were studied. Sequential implantation of the two components was feasible in sheep. After 100 days, all leads showed regular measurements of impedance, threshold, and sensing. There was no migration of either the LV lead or the CMCS. In all cases, the LV lead could be completely extracted without migration of the CMCS. There were no acute or long-term complications. CONCLUSIONS: In an animal model of healthy adult sheep, implantation of CMCS with a transvenous LV lead already in place was feasible and without major problems with either the CMCS or the LV lead. Electrical performance of the LV leads was excellent. All LV leads could be extracted without migration of the CMCS.
Authors: Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni Journal: Heart Rhythm Date: 2009-05-22 Impact factor: 6.343
Authors: Luigi Di Biase; Angelo Auricchio; Prasant Mohanty; Rong Bai; Josef Kautzner; Paolo Pieragnoli; Francois Regoli; Antonio Sorgente; Giulio Spinucci; Giuseppe Ricciardi; Antonio Michelucci; Laura Perrotta; Francesco Faletra; Hancha Mlcochová; Kamil Sedlacek; Robert Canby; Javier E Sanchez; Rodney Horton; J David Burkhardt; Tiziano Moccetti; Luigi Padeletti; Andrea Natale Journal: Europace Date: 2011-04-12 Impact factor: 5.214
Authors: Martin G St John Sutton; Ted Plappert; Kathryn E Hilpisch; William T Abraham; David L Hayes; Edward Chinchoy Journal: Circulation Date: 2006-01-09 Impact factor: 29.690
Authors: Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor Journal: Am J Cardiol Date: 2003-03-01 Impact factor: 2.778
Authors: Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert Journal: Circulation Date: 2010-01-04 Impact factor: 29.690
Authors: Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter Journal: Eur J Heart Fail Date: 2012-05-21 Impact factor: 15.534
Authors: Janusz Lipiecki; Tomasz Siminiak; Horst Sievert; Jochen Müller-Ehmsen; Hubertus Degen; Justina C Wu; Christian Schandrin; Piotr Kalmucki; Ilona Hofmann; David Reuter; Steven L Goldberg; Michael Haude Journal: Open Heart Date: 2016-07-08
Authors: Steffen D Kriechbaum; Niklas F Boeder; Luise Gaede; Martin Arnold; Ursula Vigelius-Rauch; Peter Roth; Michael Sander; Andreas Böning; Matthias Bayer; Albrecht Elsässer; Helge Möllmann; Christian W Hamm; Holger M Nef Journal: Clin Res Cardiol Date: 2019-08-26 Impact factor: 5.460